Diabetology Ltd

From Wikipedia, the free encyclopedia
Jump to: navigation, search
Diabetology Limited
Industry Biotechnology
Founded Jersey (November 13, 2002 (2002-11-13))
Headquarters Saint Helier, Jersey (registered office)
Key people
Roger New (CSO)
Glen Travers
Products 2 in clinical development and 3 in pre-clinical development
Website www.diabetology.co.uk

Diabetology Ltd is a biopharmaceutical company founded in 2002 and registered in Saint Helier, Jersey.[1]

They are currently developing oral drugs for the treatment of diabetes mellitus.[2]


Currently, the company doesn't have a marketed product, though its pipeline includes one drug that has recently completed phase II clinical development, one in phase II clinical development, and three in pre-clinical development.[3]

Drug Phase Action
Capsulin OAD Phase II clinical trial completed Oral insulin for diabetes mellitus type 2
Capsulin IR Phase II clinical trial Oral insulin for diabetes mellitus type 1
Combulin Pre-clinical development Oral combination of insulin and insulin sensitizing agents for diabetes mellitus type 2
Oral GLP-1 Pre-clinical development Improves glycaemic and diet control in diabetes mellitus type 2
Oral C-Petdide Pre-clinical development Reduces diabetic complications


External links[edit]